Posted on August 5, 2022 by George Vlahakis BLOOMINGTON, Ind. – Curative technologies and Indiana’s status as an important player in their development and implementation will be discussed at the opening event in the 2022-23 Indiana Life Sciences Collaboration Conference Series, presented by the Indiana University Kelley School of Business. Hosted by the Kelley School’s… Read more »
Entries by kconder
IU Life Sciences Day- Predictive Analytics
By Chris Anderson, MBA Class of ’22 Last Friday, the Kelley School of Business Center for the Business of Life Sciences hosted its annual Life Sciences Day in person for the first time since 2019! Our topic this year was Predictive Analytics in Healthcare, focusing on how data can be used to create models that… Read more »
Kelley conference on AI in healthcare taking place at 16 Tech Innovation District on April 29
April 19, 2022 by George Vlahakis INDIANAPOLIS — Shruti Iyer, principal innovation architect at Oracle Health Sciences, will keynote the conference, “The Potential of Artificial Intelligence and Smart Devices in Healthcare, being presented April 29 in Indianapolis by the Indiana University Kelley School of Business. Iyer will kick off the conference, the latest event in the Indiana Life Sciences… Read more »
$1 million gift supports Kelley School’s Center for the Business of Life Sciences
FOR IMMEDIATE RELEASE April 14, 2022 Share Tweet Email BLOOMINGTON, Ind. — An Indiana University Kelley School of Business center that prepares students for successful careers in life sciences and health-related firms has received a $1 million gift from alumnus Jeff Albers and his wife, Alison. The Albers Family Life Sciences Endowment will support programs within the Center… Read more »
Bloomington Area Life Sciences Companies Visit Kelley Life Sciences Students
On Thursday March 31st, the Center for the Business of Life Sciences at the Kelley School of Business hosted the Spring Life Sciences Networking reception with the purpose of connecting students with internship and job opportunities in Bloomington. The networking event was attended by over 60 students, ranging from MBAs, Masters in Sciences, MSHSMs, and… Read more »
Impact of the New Administration: HHS, FDA, CMS, Et. Al.
Summary by Chris Anderson, MBA Candidate, Class of 2022 On Friday February 18th, the Kelley School of Business’ Center for the Business of Life Sciences hosted the Indiana Life Sciences Collaboration Conference, with the theme being the Impact of the New Administration. Attendees heard from a pair of keynote speakers who provided their perspectives… Read more »
Students in Fall Life Sciences Industry From Research to Patient Course Work on Healthcare Start-Up Project
Summary by Chris Anderson, MBA Candidate 2022 Over the last seven weeks of the Fall 2021, the Master’s in Business Administration and Master’s in Health Administration students collaborated on a project for the Business of Life Sciences: Value Chain course. Teams consisted of six to seven members – two MBAs and the rest being… Read more »
Kelley MBA Alumni Return to Campus Representing Eli Lilly
The Center for the Business of Life Sciences would like to thank Eli Lilly for sponsoring an information and networking reception so students prospective students could learn about the Certificate in the Business of Life Science as well as learn more about the industry and Eli Lilly specifically along with students current in the… Read more »
Don’t Rule Out A Career in the Life Sciences Industry
Elena Rodriguez Rand, MBA Candidate ’22 Cardinal Health, Marketing Intern (Specialty Devices) *Interview by Chris Anderson, MBA ’22 What project(s) did you work on? I worked on a project called “Mini Genesis” – it was a project that had previously not worked out and they wanted to… Read more »
Former Kelley Life Sciences Course Project Receives Funding
Last fall nine teams of business and sciences students spent the semester as a part of their “Life Sciences Industry from Research to Patient” course developing a “reasonable best case” commercialization path for Kovina Therapeutics. They began by weighing the incidence and treatment alternatives of several different types of HPV infections and then recommended from… Read more »